Product labeling: GI adverse reactions and delayed gastric emptying are labeled considerations for GLP-1 receptor agonists confirm details in the FDA label for your specific medicine
In this case, 31 participants were assigned to receive 2 mg of subcutaneous exenatide once weekly, while 29 participants were assigned to the control group
The more common and less concerning side effects include nausea, changes in bowel habits, heartburn, bloating, belching, and fatigue
Maintaining Long-Term Appetite Control After 4 to 8 weeks, appetite suppression typically plateaus at a consistent level where hunger remains dramatically reduced compared to baseline
J Clin Pharm Ther 25:325332 Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE et al (2000) Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults